Pharmacy - Drug Trials News & Articles

121 The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin Current Medical Research and Opinion, May 24, 2013    Clinical Article

122 Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note Full Text Archives of Pharmacal Research, May 23, 2013    Clinical Article

123 Quintiles rated industry leader and highest in service quality in phase II/III clinical research Full Text Quintiles Transnational, May 23, 2013

124 Covidien announces clinical trial data showing endoscopic ablation therapy eliminates precancerous esophageal tissue and significantly reduces disease progression Full Text Covidien, May 23, 2013

125 Boston scientific reports lotus valve system met primary performance endpoint in reprise II trial Full Text Boston Scientific, May 23, 2013

126 Agenus announces initiation of enrollment in nci-sponsored randomized trial of prophage g-200 vaccine with avastin in treatment of brain tumors Full Text Agenus, May 23, 2013

127 NPS pharmaceuticals recognized by national organization for rare disorders for gattex as an innovative treatment for patients with short bowel syndrome Full Text NPS Pharmaceuticals, May 23, 2013

128 Results from phase III studies of naloxegol for treatment of opioid-induced constipation presented at digestive disease week 2013 Full Text AstraZeneca, May 22, 2013

129 Boston scientific long term data demonstrate bronchial thermoplasty treatment benefits persist out to five years in patients with severe asthma Full Text Boston Scientific, May 22, 2013

130 New data reinforces strength of novartis once-daily copd portfolio in improving lung function, shortness of breath and reducing rate of exacerbations Full Text Novartis, May 22, 2013

131 German federal joint committee (g-ba) issues final assessment report for pixuvri (pixantrone) Full Text Cell Therapeutics, May 22, 2013

132 Asco 2013: new phase III data reveal targeted treatment with afatinib or with nintedanib improves progression-free survival in patients with advanced NSCLC Full Text Boehringer Ingelheim, May 22, 2013

133 Phase III results: tiotropium respimat effective in symptomatic asthma patients despite at least ics/laba independent of their age, allergic status, smoking status and bronchodilator response Full Text Boehringer Ingelheim, May 22, 2013

134 Asco 2013: Boehringer Ingelheim to present highly anticipated new phase iii results for front-runner compounds afatinib and nintedanib in first- and second-line nsclc treatment Full Text Boehringer Ingelheim, May 22, 2013

135 Sanofi and regeneron announce publication of positive phase 2a results of dupilumab in asthma in the new England journal of medicine Full Text Sanofi, May 22, 2013

136 A randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis Hepatology, May 21, 2013    Clinical Article

137 Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility Full Text Pfizer, May 21, 2013

138 Site of Care May Impact Breast Cancer Management and Economic Outcomes Full Text First Report Managed Care, May 20, 2013

139 Vortioxetine clinical phase III data show significant improvement in symptoms of major depression Full Text Lundbeck, May 20, 2013

140 Takeda and Lundbeck Present Results from Pivotal Phase 3 Clinical Trials with Vortioxetine, an Investigational Compound for Major Depressive Disorder Full Text Takeda Pharmaceuticals U.S.A., May 20, 2013

1 Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development Clinical Pharmacology & Therapeutics, May 14, 2013    Review Article

2 Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study Lung Cancer, May 7, 2013

3 Delayed-release prednisone a new approach to an old therapy Expert Opinion on Pharmacotherapy, May 24, 2013

4 Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial JACC - Journal of the American College of Cardiology, May 10, 2013

5 Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer Cancer Chemotherapy and Pharmacology, May 14, 2013

6 Beyond Statins: Lipid Management to Reduce Cardiovascular Risk Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 26, 2013    Evidence Based Medicine    Review Article

7 Mifepristone for Management of Cushings Syndrome Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 12, 2013

8 Rotavirus vaccine developed in India shows positive results American Pharmacists Association News, May 17, 2013    Free full text

9 Does Acetaminophen Activate Endogenous Pain Inhibition in Chronic Fatigue Syndrome/Fibromyalgia and Rheumatoid Arthritis? A Double-Blind Randomized Controlled Cross-over Trial Pain Physician, March 25, 2013    Free full text

10 Roche to present important new data reflecting broad cancer pipeline at ASCO Roche, May 16, 2013    Free full text

11 Quintiles rated industry leader and highest in service quality in phase II/III clinical research Quintiles Transnational, May 23, 2013    Free full text

12 Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with ADHD Shire, May 10, 2013    Free full text

13 A randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis Hepatology, May 21, 2013

14 A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors Investigational New Drugs, May 9, 2013

15 Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects British Journal of Clinical Pharmacology, May 24, 2013

16 Cardiovascular Safety of Varenicline: Patient-Level Meta-Analysis of Randomized, Blinded, Placebo-Controlled Trials American Journal of Therapeutics, May 1, 2013    Evidence Based Medicine    Review Article

17 Systematic Review of CETP Inhibitors for Increasing High-Density Lipoprotein Cholesterol: Where Do These Agents Stand in the Approval Process? American Journal of Therapeutics, April 24, 2013    Evidence Based Medicine    Review Article

18 Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland The European Journal of Health Economics, May 2, 2013

19 Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation Bristol Myers-Squibb, May 7, 2013    Free full text

20 Ranibizumab: The First Vascular Endothelial Growth Factor Inhibitor Approved for the Treatment of Diabetic Macular Edema Annals of Pharmacotherapy, May 13, 2013    Review Article